-
Full Article (HTML) (57) -
Full Article (PDF) (14)
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1518)
All Articles published online
|
Aug 15, 2002 (publication date) through Jan 16, 2021
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Number | Cited Articles |
| 1 |
Seema N. Desai, Jennifer L. Dodge, Alan L. Landay, Marshall J. Glesby, Patricia S. Latham, Maria C. Villacres, Audrey L. French, Stephen J. Gange, Ruth M. Greenblatt, Marion G. Peters. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects. Medicine 2016; 95(33): e4483 doi: 10.1097/MD.0000000000004483
|
| 2 |
Vinod V. S, Vijithkumar K, Riyas C, Malini V. S, Arun S. Menon. A Study on the Role of N-Acetyl Cysteine Therapy in Acute Viral Hepatitis A. Journal of Evidence Based Medicine and Healthcare 2020; 7(22): 1068 doi: 10.18410/jebmh/2020/231
|
| 3 |
José Américo Aquino, Katia Abrahim Pegado, Lílian Patrícia Barros, Luiz Fernando Almeida Machado. Soroprevalência de infecções por vírus da hepatite B e vírus da hepatite C em indivíduos do Estado do Pará. Revista da Sociedade Brasileira de Medicina Tropical 2008; 41(4): 334 doi: 10.1590/S0037-86822008000400003
|
| 4 |
Michael L. Tapper, Eric S. Daar, Peter J. Piliero, Kimberly Smith, Corklin Steinhart. Strategies for Initiating Combination Antiretroviral Therapy. AIDS Patient Care and STDs 2005; 19(4): 224 doi: 10.1089/apc.2005.19.224
|
| 5 |
Clyde B McCoy, Lisa R Metsch, Fernando Collado-Mesa, Kristopher L Arheart, Sarah E Messiah, Dolores Katz, Paul Shapshak. The prevalence of human immunodeficiency virus type 1 and hepatitis C virus among injection drug users who use high risk inner-city locales in Miami, Florida. Memórias do Instituto Oswaldo Cruz 2004; 99(8): 789 doi: 10.1590/S0074-02762004000800002
|
| 6 |
Yu-Hua Ruan, Kun-Xue Hong, Shi-Zhu Liu, Yi-Xin He, Feng Zhou, Guan-Ming Qin, Kang-Lin Chen, Hui Xing, Jian-Ping Chen, Yi-Ming Shao. Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of China. World Journal of Gastroenterology 2004; 10(11): 1589-1593 doi: 10.3748/wjg.v10.i11.1589
|
| 7 |
Yan-Heng Zhou, Feng-Liang Liu, Zhi-Hong Yao, Lin Duo, Hong Li, Yi Sun, Yong-Tang Zheng, Volker Thiel. Comparison of HIV-, HBV-, HCV- and Co-Infection Prevalence between Chinese and Burmese Intravenous Drug Users of the China-Myanmar Border Region. PLoS ONE 2011; 6(1): e16349 doi: 10.1371/journal.pone.0016349
|
| 8 |
Alexandra Nieters, Birgit Kallinowski, Paul Brennan, Melanie Ott, Marc Maynadié, Yolanda Benavente, Lenka Foretova, Pier Luigi Cocco, Anthony Staines, Martine Vornanen, Denise Whitby, Paolo Boffetta, Nikolaus Becker, Silvia De Sanjosé. Hepatitis C and Risk of Lymphoma: Results of the European Multicenter Case-Control Study EPILYMPH. Gastroenterology 2006; 131(6): 1879 doi: 10.1053/j.gastro.2006.09.019
|
| 9 |
Yi-Biao Zhou, Song Liang, Qi-Xing Wang, Yu-Han Gong, Shi-Jiao Nie, Lei Nan, Ai-Hui Yang, Qiang Liao, Xiu-Xia Song, Qing-Wu Jiang. The geographic distribution patterns of HIV-, HCV- and co-infections among drug users in a national methadone maintenance treatment program in Southwest China. BMC Infectious Diseases 2014; 14(1) doi: 10.1186/1471-2334-14-134
|
| 10 |
David K. Henderson. Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting. Clinical Microbiology Reviews 2003; 16(3): 546 doi: 10.1128/CMR.16.3.546-568.2003
|
| 11 |
Hua-Zhang Guo, Ying Yin, Wen-Liang Wang, Chuan-Shan Zhang, Tao Wang, Zhe Wang, Jing Zhang, Hong Cheng, Hai-Tao Wang. Sequence evolution of putative cytotoxic T cell epitopes in NS3 region of hepatitis C virus. World Journal of Gastroenterology 2004; 10(6): 847-851 doi: 10.3748/wjg.v10.i6.847
|
| 12 |
Mark L Willenbring. Integrating care for patients with infectious, psychiatric, and substance use disorders: concepts and approaches. AIDS 2005; 19(Suppl 3): S227 doi: 10.1097/01.aids.0000192094.84624.c2
|
| 13 |
D. Silver, G. Karnik, A. Osinusi, R. Silk, L. Stabinski, L. Doonquah, S. Henn, G. Teferi, H. Masur, S. Kottilil, D. Fishbein. Effect of HIV on Liver Fibrosis Among HCV-Infected African Americans. Clinical Infectious Diseases 2013; 56(9): 1280 doi: 10.1093/cid/cit037
|
| 14 |
Sílvia M. Corvino, Rita M.S. Henriques, Rejane M.T. Grotto, Maria Inês de M.C. Pardini. Co-infecção HIV/HCV em pacientes de Botucatu e região. Revista Brasileira de Epidemiologia 2007; 10(4): 537 doi: 10.1590/S1415-790X2007000400012
|
| 15 |
N. A. Belyakov, B. B. Rassokhin, E. V. Boeva, L. V. Gutova, N. B. Khalezova, T. A. Stasishkis, A. Yu. Kovelenov, S. L. Plavinskiy. WOMEN CO-INFECTED WITH HIV AND VHC. PART 2. CLINICAL STATUS AND READINESS TO ANTIVIRAL THERAPY. HIV Infection and Immunosuppressive Disorders 2019; 10(4): 57 doi: 10.22328/2077-9828-2018-10-4-57-66
|
| 16 |
Carlos Arturo Rojas Rodríguez, Angelica Tobon Guevara, Mauricio Sepulveda Copete, Nelson Rojas Rojas, Diego Fernando Jimenez Rivera. Hepatitis C: una aproximación clínica y epidemiológica en Cali, Colombia. Revista Colombiana de Gastroenterología 2018; 33(4): 379 doi: 10.22516/25007440.222
|
| 17 |
J. Stebbing, L. Waters, S. Mandalia, M. Bower, M. Nelson, B. Gazzard. Hepatitis C Virus Infection in HIV Type 1--Infected Individuals Does Not Accelerate a Decrease in the CD4+ Cell Count but Does Increase the Likelihood of AIDS-Defining Events. Clinical Infectious Diseases 2005; 41(6): 906 doi: 10.1086/432885
|
| 18 |
Caterina Sagnelli, Salvatore Martini, Mariantonietta Pisaturo, Giuseppe Pasquale, Margherita Macera, Rosa Zampino, Nicola Coppola, Evangelista Sagnelli. Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact. World Journal of Hepatology 2015; 7(24): 2510-2521 doi: 10.4254/wjh.v7.i24.2510
|
| 19 |
Haleh Bagheri, Atoussa Fouladi, Karl Barange, Maryse Lapeyre-Mestre, Jean-Louis Payen, Jean Louis Montastruc, Jean-Pierre Vinel. Follow-up of Adverse Drug Reactions from Peginterferon alfa-2b–Ribavirin Therapy. Pharmacotherapy 2004; 24(11): 1546 doi: 10.1592/phco.24.16.1546.50947
|
| 20 |
Wang AiPing, Wen ChunYang, Gao Fang. Efficacy of combination therapy of interferon-α and ribavirin for HIV/HCV co-infected patients in a six-year follow-up. Proceedings 2011 International Conference on Human Health and Biomedical Engineering 2011; : 171 doi: 10.1109/HHBE.2011.6027926
|
| 21 |
J. Alberto Juárez Navarro. Treatment of HCV and HIV coinfection. Annals of Hepatology 2006; 5: S42 doi: 10.1016/S1665-2681(19)31971-4
|
| 22 |
Laura Waters, Justin Stebbing, Sundhiya Mandalia, Anne Marie Young, Mark Nelson, Brian Gazzard, Mark Bower. Hepatitis C infection is not associated with systemic HIV-associated non-hodgkin's lymphoma: A cohort study. International Journal of Cancer 2005; 116(1): 161 doi: 10.1002/ijc.20988
|
| 23 |
Lydia M. Petrovic. HIV/HCV co-infection: histopathologic findings, natural history, fibrosis, and impact of antiretroviral treatment: a review article. Liver International 2007; 27(5): 598 doi: 10.1111/j.1478-3231.2007.01478.x
|
| 24 |
Huseyin Gunduz, Oguz Karabay, Ali Tamer, Resat Özaras, Ali Mert, Ömer Fehmi Tabak. N-acetyl cysteine therapy in acute viral hepatitis. World Journal of Gastroenterology 2003; 9(12): 2698-2700 doi: 10.3748/wjg.v9.i12.2698
|
| 25 |
D. SIMON, R. T. MICHITA, J. U. BÉRIA, D. C. TIETZMANN, A. T. STEIN, V. R. LUNGE. Alcohol misuse and illicit drug use are associated with HCV/HIV co-infection. Epidemiology and Infection 2014; 142(12): 2616 doi: 10.1017/S0950268814000041
|
| 26 |
Justin STEBBING, Steve PATTERSON, Simon PORTSMOUTH, Claire THOMAS, Robert GLASSMAN, Adrian WILDFIRE, Frances GOTCH, Mark BOWER, Mark NELSON, Brian GAZZARD. Studies on the allostimulatory function of dendritic cells from HCV-HIV-1 co-infected patients. Cell Research 2004; 14(3): 251 doi: 10.1038/sj.cr.7290226
|
| 27 |
Noha H. Farag, Hebat-Allah Rashed, Magda Hassan, Alaa Darweesh, Mohamed Shehata, Tarek Hassanein, Paul J. Mills. Hepatitis C infection, Cognition, and inflammation in an Egyptian sample. Journal of Medical Virology 2011; 83(2): 261 doi: 10.1002/jmv.21879
|
| 28 |
Sana Mansha, Muhammad Imran, Amir Miraj Ul Hussain Shah, Muhsin Jamal, Fayyaz Ahmed, Muhammad Atif, Muhammmad Saleem, Sher Zaman Safi, Zareen Fatima, Ahmed Bilal Waqar. Hepatitis B and C Virus Infections Among Human Immunodeficiency Virus-Infected People Who Inject Drugs in Lahore, Pakistan. Viral Immunology 2017; 30(5): 366 doi: 10.1089/vim.2016.0144
|
| 29 |
Seng-Lai Tan, Arnim Pause, Yuguang Shi, Nahum Sonenberg. Hepatitis C therapeutics: current status and emerging strategies. Nature Reviews Drug Discovery 2002; 1(11): 867 doi: 10.1038/nrd937
|
| 30 |
Shaodong Ye, Lin Pang, Xiaochun Wang, Zhongfu Liu. Epidemiological Implications of HIV-Hepatitis C Co-Infection in South and Southeast Asia. Current HIV/AIDS Reports 2014; 11(2): 128 doi: 10.1007/s11904-014-0206-z
|
| 31 |
Yi-Biao Zhou, Qi-Xing Wang, Song Liang, Yu-Han Gong, Mei-xia Yang, Shi-Jiao Nie, Lei Nan, Ai-Hui Yang, Qiang Liao, Yang Yang, Xiu-Xia Song, Qing-Wu Jiang, Wenzhe Ho. HIV-, HCV-, and Co-Infections and Associated Risk Factors among Drug Users in Southwestern China: A Township-Level Ecological Study Incorporating Spatial Regression. PLoS ONE 2014; 9(3): e93157 doi: 10.1371/journal.pone.0093157
|
| 32 |
Mohamed A Daw, Abdallah El-Bouzedi, Aghnaya A Dau. Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission. BMC Research Notes 2015; 8(1) doi: 10.1186/s13104-015-1310-x
|
| 33 |
Milos Opravil, Joe Sasadeusz, David A Cooper, Jürgen K Rockstroh, Nathan Clumeck, Bonaventura Clotet, Julio Montaner, Francesca J Torriani, Jean DePamphilis, Douglas T Dieterich. Effect of Baseline CD4 Cell Count on the Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Patients With HIV/Hepatitis C Virus Coinfection. JAIDS Journal of Acquired Immune Deficiency Syndromes 2008; 47(1): 36 doi: 10.1097/QAI.0b013e31815ac47d
|
| 34 |
Edison Mayanja, Livingstone S. Luboobi, Juma Kasozi, Rebecca N. Nsubuga, Raul Alcaraz. Mathematical Modelling of HIV-HCV Coinfection Dynamics in Absence of Therapy. Computational and Mathematical Methods in Medicine 2020; 2020: 1 doi: 10.1155/2020/2106570
|
| 35 |
Laurie L. Kenney, Markus Cornberg, Alex T. Chen, Sebastien Emonet, Juan Carlos de la Torre, Liisa K. Selin, S. Perlman. Increased Immune Response Variability during Simultaneous Viral Coinfection Leads to Unpredictability in CD8 T Cell Immunity and Pathogenesis. Journal of Virology 2015; 89(21): 10786 doi: 10.1128/JVI.01432-15
|
| 36 |
Ching-Hsuan Liu, Alagie Jassey, Hsin-Ya Hsu, Liang-Tzung Lin. Antiviral Activities of Silymarin and Derivatives. Molecules 2019; 24(8): 1552 doi: 10.3390/molecules24081552
|
| 37 |
Brent Wise, Renan Castillo, Manjari Joshi, Robert V. O’Toole. Will My Fracture Surgery Get Infected? Evidence-based Risk Factors. Techniques in Orthopaedics 2020; 35(2): 100 doi: 10.1097/BTO.0000000000000421
|
| 38 |
Veronna Marie, Johnson Lin. Viruses in the environment – presence and diversity of bacteriophage and enteric virus populations in the Umhlangane River, Durban, South Africa. Journal of Water and Health 2017; 15(6): 966 doi: 10.2166/wh.2017.066
|
| 39 |
Anita Kohli, Emily Funk, Peter Burbelo, Lisa Barrett, Eric G. Meissner, Brian Santich, Ashton Shaffer, Jessica Johl, Sreetha Sidharthan, Susan Moir, Shyam Kottilil, Anthony S. Fauci. Persistently elevated abnormal B-cell subpopulations and anti-core antibodies in patients co-infected with HIV/HCV who relapse. Journal of Medical Virology 2015; 87(4): 544 doi: 10.1002/jmv.24089
|